selenium has been researched along with Graves Ophthalmopathy in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 15 (60.00) | 24.3611 |
| 2020's | 10 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckstein, A; Führer, D; Möller, L; Oeverhaus, M | 1 |
| Kim, BR; Kim, TH; Ko, J; Lee, EJ; Shin, DY; Yoon, JS | 1 |
| Gur, Z; Vashdi, I | 1 |
| Freitas, C; Gaspar da Rocha, A; Neves, C; Santos, LR; Soares, P; Vasconcelos Bessa, I | 1 |
| Cui, L; Li, C; Li, S; Liao, L; Wang, F; Zhao, J | 1 |
| Ahn, HY; Cho, SW; Chung, CW; Jung, EH; Jung, KY; Lee, JK; Lee, MJ; Park, YJ | 1 |
| Bednarczuk, T; Schomburg, L | 1 |
| Chen, Z; Ding, X; He, M; Shi, B; Sui, J; Wang, J; Wang, Y; Xie, B; Zhang, M; Zhao, Y | 1 |
| Lanzolla, G; Marcocci, C; Marinò, M | 1 |
| Almanza-Monterrubio, M; Dávila-Camargo, A; Garnica-Hayashi, L; Nava-Castañeda, Á | 1 |
| Bonnema, SJ; Hegedüs, L; Winther, KH | 1 |
| Federige, MAF; Koike, MK; Miklos, ABPP; Portes, ES; Romaldini, JH; Takei, K | 1 |
| Dottore, GR; Leo, M; Marcocci, C; Marinò, M | 1 |
| Genere, N; Stan, MN | 1 |
| Burdon, KP; Craig, JE; Ebeling, PR; Goldstein, RF; Khong, JJ; Pope, J; Sanders, KM; Schneider, H | 1 |
| Barna, S; Berta, E; Bodor, M; Erdei, A; Galuska, L; Gazdag, A; Győry, F; Katkó, M; Nagy, VE; Steiber, Z; Ujhelyi, B; Urbancsek, H | 1 |
| Escobar-Barranco, JJ; Fagúndez-Vargas, MA; Lamas-Oliveira, C; Merayo-Lloves, J; Núñez-Quintanilla, AT; Pérez-Rozos, A; Rico-Pérez, JM; Vilar-González, S | 1 |
| Casini, G; Cestari, L; Latrofa, F; Leo, M; Marcocci, C; Marinò, M; Nardi, M; Rotondo Dottore, G; Sellari-Franceschini, S; Vitti, P | 1 |
| Casini, G; Cestari, L; Chiarini, R; De Gregorio, M; Leo, M; Marcocci, C; Marinò, M; Nardi, M; Rotondo Dottore, G; Sellari-Franceschini, S; Vitti, P | 1 |
| Altea, MA; Baldeschi, L; Bartalena, L; Bencivelli, W; Boboridis, K; Kahaly, GJ; Krassas, GE; Marcocci, C; Mourits, MP; Nardi, M; Pitz, S; Prummel, M; Sivelli, P; Stahl, M; von Arx, G; Wiersinga, W | 1 |
| Douglas, RS; Smith, TJ | 1 |
| Sheck, L | 1 |
| Weissel, M | 1 |
| Park, SJ; Shin, JI | 1 |
| Fratianni, C; Gonzales, M; Khardori, R; Mamillapali, C | 1 |
11 review(s) available for selenium and Graves Ophthalmopathy
| Article | Year |
|---|---|
[Graves' orbitopathy].
Topics: Administration, Intravenous; Antibodies, Monoclonal, Humanized; Antioxidants; Decompression, Surgical; Graves Ophthalmopathy; Humans; Lubricant Eye Drops; Orbit; Receptor, IGF Type 1; Risk Factors; Selenium; Smoking Cessation; Steroids | 2021 |
[LIFESTYLE ADJUSTMENT AS THERAPEUTIC TOOL IN THYROID EYE DISEASE].
Topics: Graves Disease; Graves Ophthalmopathy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Quality of Life; Randomized Controlled Trials as Topic; Selenium | 2022 |
Selenium and thyroid diseases.
Topics: Graves Ophthalmopathy; Humans; Quality of Life; Selenium; Selenoproteins; Thyroid Diseases | 2023 |
Challenges and perspectives of selenium supplementation in Graves' disease and orbitopathy.
Topics: Antithyroid Agents; Chemotherapy, Adjuvant; Dietary Supplements; Graves Disease; Graves Ophthalmopathy; Humans; Quality of Life; Randomized Controlled Trials as Topic; Selenium; Time Factors | 2020 |
Selenium in the Treatment of Graves' Hyperthyroidism and Eye Disease.
Topics: Antioxidants; Graves Disease; Graves Ophthalmopathy; Humans; Selenium; Selenoproteins; Treatment Outcome | 2020 |
Is selenium supplementation in autoimmune thyroid diseases justified?
Topics: Autoantibodies; Dietary Supplements; Graves Disease; Graves Ophthalmopathy; Humans; Quality of Life; Selenium; Thyroiditis, Autoimmune | 2017 |
Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy.
Topics: Fibroblasts; Graves Ophthalmopathy; Humans; Oxidative Stress; Quality of Life; Selenium; Surveys and Questionnaires | 2018 |
Current and Emerging Treatment Strategies for Graves' Orbitopathy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunotherapy; Methotrexate; Mycophenolic Acid; Rituximab; Selenium; Severity of Illness Index | 2019 |
[Novel treatment opportunities in Graves' orbitopathy].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Etanercept; Graves Ophthalmopathy; Humans; Immunoglobulin G; Immunologic Factors; Infliximab; Receptors, Tumor Necrosis Factor; Rituximab; Selenium; Tumor Necrosis Factor-alpha | 2014 |
[Thyroid orbitopathy, an overview with special attention to the role of radiotherapy].
Topics: Adrenal Cortex Hormones; Combined Modality Therapy; Decompression, Surgical; Double-Blind Method; Female; Graves Ophthalmopathy; Humans; Incidence; Male; Models, Biological; Pentoxifylline; Radiation Injuries; Radiotherapy, High-Energy; Randomized Controlled Trials as Topic; Selenium; Smoking | 2015 |
Immunotherapy in miscellaneous medical disorders Graves ophthalmopathy, asthma, and regional painful syndrome.
Topics: Allergens; Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antioxidants; Asthma; Azathioprine; Benzamides; Complex Regional Pain Syndromes; Cyclosporine; Decompression, Surgical; Etanercept; Glucocorticoids; Graves Ophthalmopathy; Humans; Imatinib Mesylate; Immunoglobulin G; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Octreotide; Omalizumab; Orbit; Piperazines; Pyridones; Pyrimidines; Radiotherapy Dosage; Receptors, Tumor Necrosis Factor; Risk Factors; Rituximab; Selenium | 2012 |
3 trial(s) available for selenium and Graves Ophthalmopathy
| Article | Year |
|---|---|
Efficacy of selenium supplementation for mild-to-moderate Graves' ophthalmopathy in a selenium-sufficient area (SeGOSS trial): study protocol for a phase III, multicenter, open-label, randomized, controlled intervention trial.
Topics: Clinical Trials, Phase III as Topic; Dietary Supplements; Graves Ophthalmopathy; Humans; Multicenter Studies as Topic; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Selenium; Vitamin B Complex | 2023 |
Oral selenium improved the disease activity in patients with mild Graves' orbitopathy.
Topics: Antioxidants; Graves Disease; Graves Ophthalmopathy; Humans; Oxidative Stress; Selenium | 2021 |
Selenium and the course of mild Graves' orbitopathy.
Topics: Adult; Anti-Inflammatory Agents; Antioxidants; Disease Progression; Double-Blind Method; Female; Graves Ophthalmopathy; Humans; Male; Pentoxifylline; Quality of Life; Selenium | 2011 |
11 other study(ies) available for selenium and Graves Ophthalmopathy
| Article | Year |
|---|---|
Serum Selenium Levels in Patients with Graves Disease: Associations with Clinical Activity and Severity in a Retrospective Case-control Study.
Topics: Case-Control Studies; Graves Disease; Graves Ophthalmopathy; Humans; Retrospective Studies; Selenium | 2022 |
Survey on selenium clinical supplementation in autoimmune thyroid disease.
Topics: Cross-Sectional Studies; Dietary Supplements; Graves Disease; Graves Ophthalmopathy; Hashimoto Disease; Humans; Selenium; Surveys and Questionnaires | 2023 |
The potential markers involved in newly diagnosed graves' disease and the development of active graves' orbitopathy.
Topics: Adult; Biomarkers; Cytokines; Female; Graves Disease; Graves Ophthalmopathy; Humans; Male; Middle Aged; Selenium; Th1 Cells; Th17 Cells | 2020 |
Serum selenium and selenoprotein-P levels in autoimmune thyroid diseases patients in a select center: a transversal study.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Disease Progression; Female; Graves Disease; Graves Ophthalmopathy; Hashimoto Disease; Humans; Male; Middle Aged; Selenium; Selenoprotein P; Spectrophotometry, Atomic | 2017 |
Serum selenium status in Graves' disease with and without orbitopathy: a case-control study.
Topics: Aged; Australia; Case-Control Studies; Disease Progression; Female; Graves Disease; Graves Ophthalmopathy; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Selenium | 2014 |
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy.
Topics: Aged; Antioxidants; Case-Control Studies; Cell Proliferation; Cells, Cultured; Cytokines; Female; Fibroblasts; Glutathione Disulfide; Glutathione Peroxidase; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Hydrogen Peroxide; Male; Middle Aged; Orbit; Oxidants; Oxidative Stress; Selenium; Selenocysteine | 2017 |
Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves' orbitopathy.
Topics: Adipose Tissue; Aged; Cell Death; Cells, Cultured; Cytoprotection; Female; Fibroblasts; Graves Ophthalmopathy; Humans; Hydrogen Peroxide; Male; Middle Aged; Orbit; Primary Cell Culture; Selenium; Signal Transduction | 2017 |
Pharmacotherapy: does selenium supplementation improve Graves ophthalmopathy?
Topics: Graves Ophthalmopathy; Humans; Pentoxifylline; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Selenium | 2011 |
Selenium and the course of mild Graves' orbitopathy.
Topics: Antioxidants; Diabetes Mellitus, Type 2; Glaucoma; Graves Ophthalmopathy; Humans; New Zealand; Pentoxifylline; Peripheral Vascular Diseases; Selenium; Soil | 2011 |
Selenium and the course of mild Graves' orbitopathy.
Topics: Antioxidants; Diabetes Mellitus, Type 2; Graves Ophthalmopathy; Humans; Pentoxifylline; Selenium | 2011 |
The role of IL-15 and selenium in Graves ophthalmopathy.
Topics: Graves Ophthalmopathy; Humans; Selenium | 2011 |